This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CIRARA

Remedy Pharmaceuticals Inc.

Drug Names(s): Glyburide, RP-1127, glibenclamide, glybenclamide

Description: CIRARA is a formulation of glyburide (5-chloro-N-(4-[N-(cyclohexylcarbamoyl) sulfamoyl]phenethyl)-2- methoxybenzamide) designed for intravenous administration. It acts as a high affinity inhibitor of Sur1-Trpm4 channels, which are upregulated following ischemia and trauma.


CIRARA News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug